top of page

Fulvetraz 250 mg Injection

SKU Alkem Laboratories Ltd
原始價格

$179,03

促銷價格

$139,64

Fulvetraz 250 mg injection is a targeted anticancer therapy designed to treat breast cancer in postmenopausal women, particularly those with hormone receptor (HR)-positive and HER2-negative forms of the disease. Often used in combination with palbociclib, this medication is indicated for patients with locally advanced or metastatic breast cancer who have previously undergone endocrine therapy. Fulvetraz operates by effectively lowering estrogen levels in the body, which helps to slow the proliferation of hormone-dependent cancer cells. It’s essential for patients to be aware of potential side effects and to discuss any underlying health conditions with their healthcare provider before starting treatment. This injection may not be suitable for individuals with certain medical histories or those who are pregnant or breastfeeding. By managing estrogen's influence, Fulvetraz plays a crucial role in the fight against advanced breast cancer, offering hope to many women battling this condition. Always consult with your healthcare team to ensure the best treatment plan tailored to your individual needs.

數量

Active Pharmaceutical Ingredient

Fulvestrant 250 mg

Uses

• Fulvetraz 250 mg injection is primarily utilized in the treatment of hormone receptor-positive breast cancer. This medication helps to slow down the growth of cancer cells by blocking estrogen receptors in the body. Patients with advanced breast cancer often receive this injection to manage their symptoms effectively. By doing so, Fulvetraz 250 mg injection aims to improve overall quality of life.
• In addition to treating advanced breast cancer, Fulvetraz 250 mg injection is also indicated for patients who have experienced disease progression following initial therapy. It can be used when other treatments, such as aromatase inhibitors, have failed to yield positive results. The administration of Fulvetraz 250 mg injection can help control the disease and provide symptomatic relief. This is particularly important for maintaining patient comfort during treatment.
• Fulvetraz 250 mg injection is often prescribed as part of a comprehensive treatment plan for postmenopausal women. It targets specific hormonal pathways that are crucial for the growth of certain breast tumors. By effectively managing hormone levels, Fulvetraz 250 mg injection can help to stabilize the condition and prevent further progression. This approach allows healthcare providers to tailor treatments based on individual patient needs.
• Healthcare professionals may recommend Fulvetraz 250 mg injection for patients with breast cancer who have not responded well to other therapies. Its unique mechanism of action offers an alternative option for those in need of additional treatment. The use of Fulvetraz 250 mg injection can be beneficial in prolonging disease control. This is especially relevant for patients seeking to maintain their daily activities and improve their overall well-being.

Benefits

Fulvetraz Injection effectively reduces the symptoms associated with breast cancer, such as breast lumps, bloody nipple discharge, or changes in the shape or texture of the breast. Its mechanism of action involves altering the production of hormones that are essential for the growth and metastasis of breast cancer cells. It may also interact with other hormones or directly inhibit cancer growth. It is essential to receive Fulvetraz 250 Injection by injection from a doctor or nurse as self-administration is not recommended.It is important to look at your doctor's instructions carefully.

Side Effects

As with all medicines, Fulvetraz 250 mg Injection may cause some side effects. If you experience any of these side effects, you should contact your doctor or health care professional as soon as possible. Your doctor may be able to suggest ways in which these side effects can be managed or the severity of them reduced.

Most Common Side Effects

• Back pain
• Diarrhoea
• Vaginal bleeding
• Muscle and Joint pain
• Reaction in the injection site
• Vomiting
• Nausea
• Numbness
• Appetite loss
• Sweating
• Infection in the urinary tract

Common Side Effects

• Blood clots
• Low platelets count
• Liver failure
• Swelling in tongue, mouth, throat, and face

How To Use

The Fulvetraz 250 mg Injection is administered by a healthcare professional or nurse in a hospital or clinic setting by intravenous infusion under the skin. The specific dosage and administration of Fulvetraz 250 mg Injection will be determined by the patient's clinical condition, age, medical history, and other factors. It is important to note that this Fulvetraz 250 mg should not be self-administered, and it is important to follow the instructions of the healthcare professional administering the Fulvetraz 250 mg Injection.

Safety Advice

• Alcohol: It is generally not recommended to drink alcohol while taking Fulvetraz Injection. It may increase the risk of liver damage. it is best to avoid alcohol or limit your alcohol consumption while taking any medication.
• Kidney: Fulvetraz 250 mg should be used with caution in patients with kidney disease. It is important that patients with kidney disease closely monitor kidney function while taking Fulvetraz 250 mg Injection and report any unusual symptoms or changes in kidney function to their doctor. The dose of Fulvetraz 250 mg may need to be adjusted in patients with kidney disease.
• Breastfeeding: It is not recommended to breastfeed while taking Fulvetraz 250 Injection. Fulvetraz Injection may pass into breast milk and harm the infant. If you are breastfeeding and taking Fulvetraz 250 mg, it is important to talk to your doctor about the possible risks and benefits of continuing to breastfeed. Your doctor will be able to help you make the best decision for you and your baby's health.
• Liver: Fulvetraz 250 Injection should be used with caution in patients with liver disease. It is important that patients with liver disease closely monitor liver function while taking Fulvetraz 250 mg and report any unusual symptoms or changes in liver function to their doctor. The dose of Fulvetraz 250 Injection may need to be adjusted in patients with liver disease.
• Pregnancy: Use of Fulvetraz 250 mg Injection may be unsafe during pregnancy, as animal studies indicate that it may harm the developing fetus. However, if you are pregnant or planning to become pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Fulvetraz 250 mg during pregnancy. Your doctor will be able to help you make the best decision for you and your baby's health.
• Driving: Fulvetraz 250 mg Injection is unlikely to affect your ability to drive or operate machinery. If you experience any side effects while taking Fulvetraz 250 Injection such as dizziness or drowsiness, it is important to avoid driving or operating heavy machinery until the side effects have resolved.

bottom of page